Altered expression of neurotransmitter receptors and neuromediators in vernal keratoconjunctivitis

Archives of Ophthalmology

Volumn 124, Issue 4, 2006, Pages 462-468

  Motterle, Laura ^a   Diebold, Yolanda ^b   Enríquez De Salamanca, Amalia ^b   Saez, Victoria ^b   Garcia Vazquez, Carmen ^b   Stern, Michael E ^c   Calonge, Margarita ^b   Leonardi, Andrea ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF VALLADOLID   (Spain)

^c ALLERGAN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; BETA 1 ADRENERGIC RECEPTOR; CELL MARKER; GENE PRODUCT; MUSCARINIC M1 RECEPTOR; MUSCARINIC M1 RECEPTOR ANTAGONIST; MUSCARINIC M2 RECEPTOR; MUSCARINIC M2 RECEPTOR ANTAGONIST; MUSCARINIC M3 RECEPTOR; MUSCARINIC M3 RECEPTOR ANTAGONIST; NERVE GROWTH FACTOR; NEUROTRANSMITTER; NEUROTRANSMITTER RECEPTOR; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADOLESCENT; ARTICLE; ATOPY; AUTONOMIC DYSFUNCTION; CELL INFILTRATION; CELLULAR DISTRIBUTION; CLINICAL ASSESSMENT; CONJUNCTIVAL BIOPSY; CONTROLLED STUDY; CORNEA STROMA; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NERVE FIBER; NEUROGENIC INFLAMMATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; TISSUE SECTION; VERNAL CONJUNCTIVITIS;

ADOLESCENT; AUTONOMIC NERVOUS SYSTEM; BIOLOGICAL MARKERS; CHILD; CONJUNCTIVA; CONJUNCTIVITIS, ALLERGIC; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; NERVE FIBERS; NERVE GROWTH FACTORS; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, MUSCARINIC; UBIQUITIN THIOLESTERASE; VASOACTIVE INTESTINAL PEPTIDE;

EID: 33645865833     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.124.4.462     Document Type: Article

References (39)

1. Downing JEG, Miyan JA. Neural immunoregulation: emerging roles for nerves in immune homeostasis and disease. Immunol Today. 2000;21:281-289.
2. Savino W, Dardenne M. Immune-neuroendocrine interactions. Immunol Today. 1995;16:318-322.
3. Webster JI, Tonelli L, Sternberg EM. Neuroendocrine regulation of immunity. Annu Rev Immunol. 2002;20:125-163.
4. Blalock JE. The syntax of immune-neuroendocrine communication. Immunol Today. 1994;15:504-511.
5. Stanisz A, Scicchitano R, Stead R, et al. Neuropeptides and immunity. Am Rev Respir Dis. 1987;136(pt 2):S48-S51.
6. Frieri M. Neuroimmunology and inflammation: implications for therapy of allergic and autoimmune diseases. Ann Allergy Asthma Immunol. 2003;90:34-40.
7. Befus AD, Mathison R, Davison J. Integration of neuro-immune responses in defense of mucosal surfaces. Am J Trop Med Hyg. 1999;60(suppl):26-34.
8. Sternberg EM. Neuroendocrine regulation of autoimmune/inflammatory disease. J Endocrinol. 2001;169:429-435.
9. Dartt DA. Regulation of lacrimal gland secretion by neurotransmitters and the EGF family of growth factors. Exp Eye Res. 2001;73:741-752.
10. Dartt DA. Regulation of mucin and fluid secretion by conjunctival epithelial cells. Prog Retin Eye Res. 2002;21:555-576.
11. Sullivan DA, Belanger A, Cermak JM, et al. Are women with Sjogren's syndrome androgen-deficient? J Rheumatol. 2003;30:2413-2419.
12. Jones MA, Marfurt CF. Sympathetic stimulation of corneal epithelial proliferation in wounded and nonwounded rat eyes. Invest Ophthalmol Vis Sci. 1996;37:2535-2547.
13. Stern ME. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea. 1998;17:584-589.
14. Stern ME, Gao J, Siemasko KF, Beuerman RW, Pflugfelder SC. The role of the lacrimal unit in the pathophysiology of dry eye. Exp Eye Res. 2004;78:409-416.
15. Leonardi A. Vernal keratoconjunctivitis: pathogenesis and treatment. Prog Retin Eye Res. 2002;21:319-339.
16. Bonini S, Bonini S, Todini V, et al. Conjunctival hyperresponsiveness to ocular histamine challenge in patients with vernal keratoconjunctivitis. J Allergy Clin Immunol. 1992;89:103-107.
17. Abelson MB, Leonardi A, Smith LM, Fregona IA, George M, Secchi AG. Histaminase activity in patients with vernal keratoconjunctivitis. Ophthalmology. 1995;102:1958-1963.
18. Lambiase A, Bonini S, Bonini S, et al. Increased plasma levels of nerve growth factor in vernal keratoconjunctivitis and relationship to conjunctival mast cells. Invest Ophthalmol Vis Sci. 1995;36:2127-2132.
19. Lambiase A, Bonini S, Micera A, Rama A, Bonini S, Aloe L. Expression of nerve growth factor receptors on the ocular surface in healthy subjects and during manifestation of inflammatory diseases. Invest Ophthalmol Vis Sci. 1998;39:1272-1275.
20. Fujishima H, Takeyama M, Takeuchi T, Saito I, Tsubota K. Elevated levels of substance P in tears of patients with allergic conjunctivitis and vernal keratoconjunctivitis. Clin Exp Allergy. 1997;27:372-378.
21. Lambiase A, Bonini S, Micera A, et al. Increased plasma levels of substance P in vernal keratoconjunctivitis. Invest Ophthalmol Vis Sci. 1997;38:2161-2164.
22. Undem BJ, Kajekar R, Hunter DD, Myers AC. Neural integration and allergic disease. J Allergy Clin Immunol. 2000;106(suppl):S213-S220.
23. Diebold Y, Rios JD, Hodges RR, Rawe I, Dartt DA. Presence of nerves and their receptors in mouse and human conjunctival goblet cells. Invest Ophthalmol Vis Sci. 2001;42:2270-2282.
24. Kantelip B, Creuzot-Garcher C. Anatomy. In: Thang H-X, Badoiun C, Creuzot-Garcher C, eds. Chronic Inflammation of the Conjunctiva. Paris, France: Thieme Publishing Group; 2001:1-23.
25. Vujkovic V, Mikac G, Kozomara R. Distribution and density of conjunctival goblet cells. Med Pregl. 2002;55:195-200.
26. Rogers DF. Motor control of airway goblet cells and glands. Respir Physiol. 2001;125:129-144.
27. Casale TB, Baraniuk JN. Neurogenic control of inflammation and airway function. In: Middleton E, Reed CE, Ellis ET, Adkinson NF, Yunginger JW, Busse WW, eds. Allergy: Principles and Practice. St Louis, Mo: Mosby-Year Book; 1998:183-203.
28. Fox AJ, Patel HJ, Barnes PJ, Belvisi MG. Release of nerve growth factor by human pulmonary epithelial cells: role in airway inflammatory diseases. Eur J Pharmacol. 2001;424:159-162.
29. Leonardi A. The central role of conjunctival mast cells in the pathogenesis of ocular allergy. Curr Allergy Asthma Rep. 2002;2:325-331.
30. Reinheimer T, Baumgartner D, Hohle KD, Rackè K, Wessler I. Acetylcholine via muscarinic receptors inhibits histamine release from human isolated bronchi. Am J Respir Crit Care Med. 1997;156(pt 1):389-395.
31. Reinheimer T, Möhlig T, Zimmermann S, Dieter Höhle S, Wessler I. Muscarinic control of histamine release from airways. Am J Respir Crit Care Med. 2000;162:534-538.
32. Irani AMA, Butrus SI, Tabbara KF, Schwartz LB. Human conjunctival mast cells: distribution of MCt and MCtc in vernal conjunctivitis and giant papillary conjunctivitis. J Allergy Clin Immunol. 1990;86:34-39.
33. Ricci A, Amenta F, Bronzetti E, Mannino F, Mariotta S, Tayebati SK. Expression of peripheral blood lymphocyte muscarinic cholinergic receptor subtypes in airway hyperresponsiveness. J Neuroimmunol. 2002;129:178-185.
34. 2 receptor. J Clin Invest. 1993;91:1314-1318.
35. Jacoby DB, Costello RM, Fryer AD. Eosinophil recruitment to the airway nerves. J Allergy Clin Immunol. 2001;107:211-218.
36. Delgado M, Pozo D, Ganea D. The significance of vasoactive intestinal peptide in immunomodulation. Pharmacol Rev. 2004;56:249-290.
37. Tanaka A, Wakita U, Kambe N, Iwasaki T, Matsuda H. An autocrine function of nerve growth factor for cell cycle regulation of vascular endothelial cells. Biochem Biophys Res Commun. 2004;313:1009-1014.
38. Bonini S, Rasi G, Bracci-Laudero ML, Procoli A, Aloe L. Nerve growth factor: neurotrophin or cytokine? Int Arch Allergy Immunol. 2003;131:80-84.
39. Enriquez de Salamanca A, Siemasko KF, Diebold Y, et al. Expression of muscarinic and adrenergic receptors in normal human conjunctival epithelium. Invest Ophthalmol Vis Sci. 2005;46:504-513.